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Introduction {#sec1}
============

Genetic studies indicate a strong role for the CNS in the development of obesity, especially for genes expressed in the hypothalamus ([@bib43], [@bib60]). Nevertheless, how a high-fat diet (HFD) affects the central regulation of feeding remains largely elusive. Exposure to a HFD leads to acute hyperphagia, which is potentially caused by the difference in postingestive signals arising from carbohydrate and fat consumption ([@bib7], [@bib26], [@bib27], [@bib64], [@bib70]). In addition, acute and/or prolonged feeding of a HFD alters the secretion of gastrointestinal hormones ([@bib55], [@bib72]) and impairs vagal afferent sensitivity ([@bib17], [@bib39]). In the brain, highly dynamic neuronal networks in the hypothalamus integrate anticipatory responses, postingestive signals, and systemic metabolic homeostasis. In particular, the orexigenic agouti-related peptide (AgRP)-expressing and the anorexigenic proopiomelanocortin (POMC)-expressing neurons in the arcuate nucleus of the hypothalamus (ARC) express receptors for sensing the organismal energy state, allowing for accurate feedback regulation ([@bib5], [@bib25], [@bib37]). For example, increased blood glucose concentrations and release of the adipokine leptin inform the brain about the sufficiency of energy stores and act via the activation of satiety signaling POMC neurons ([@bib16], [@bib35]) and inhibition of hunger-signaling AgRP/NPY (neuropeptide Y) neurons ([@bib24], [@bib68]). In addition, sensory food perception transiently regulates POMC neuron activity to prime postprandial liver adaptation ([@bib8]). However, continuous and prolonged HFD feeding results in impaired glucose sensing by POMC neurons ([@bib50]), altered mitochondrial dynamics and mitochondria-endoplasmic reticulum (ER) interactions ([@bib19], [@bib58]), and ultimately inhibition of POMC neuron firing via the deterioration of Ca^2+^ homeostasis ([@bib49]).

Here, we set out to characterize neuronal populations that specifically respond to the feeding of energy-dense, highly palatable food. Using an unbiased phosphoribotrap approach, we find that prepronociceptin (PNOC)-expressing neurons in the hypothalamus are activated upon acute HFD feeding, and specifically, PNOC-expressing neurons in the ARC (PNOC^ARC^ neurons) provide inhibitory synaptic contact to anorexigenic POMC neurons. Their activity promotes overconsumption during acute HFD feeding, making PNOC-expressing neurons an attractive target for the prevention and treatment of obesity and associated metabolic diseases.

Results {#sec2}
=======

PNOC^ARC^ Neurons Are Activated upon Short-Term HFD Feeding {#sec2.1}
-----------------------------------------------------------

To identify novel neurocircuits activated upon short-term HFD feeding, we used phosphoribotrap profiling ([@bib41]) via immunoprecipitation of phosphorylated S6 ribosomal protein-tagged ribosomes from hypothalamic extracts of mice exposed to either 3 days of normal chow diet (NCD) or HFD ([Figure S1](#mmc1){ref-type="supplementary-material"}A). The extraction of RNA from precipitated ribosomes allowed for the comparison of mRNA expression both in the input RNA and following pull-down of pS6-bearing ribosomes under both diet conditions. Only minor differences were observed between the input RNA fractions ([Figure S1](#mmc1){ref-type="supplementary-material"}B). However, when we compared the input normalized immunoprecipitation (IP)-associated mRNAs, we detected transcripts that were significantly enriched in association with pS6-labeled ribosomes in hypothalamic extracts of mice exposed to HFD feeding for 3 days ([Figure 1](#fig1){ref-type="fig"}A). Among these transcripts, the mRNA encoding the neuropeptide PNOC (*Pnoc*) exhibited a significant enrichment in ribosomes precipitated from cells activated upon HFD feeding ([Figures 1](#fig1){ref-type="fig"}B and 1C). We next overlaid our dataset with a published single-cell-sequencing dataset of cells in the ARC of mice ([@bib10]). Analysis of activated cell clusters based on our phosphoribotrap data identified *Pnoc* as a characteristic marker of neurons activated by HFD feeding ([Figure S1](#mmc1){ref-type="supplementary-material"}C). In addition, when we analyzed the top 50 most significantly enriched transcripts upon HFD feeding, *Pnoc* was the only transcript characterizing the Gene Ontology (GO) term "neuropeptide signaling pathway" (GO: 0007218; [Table S1](#mmc1){ref-type="supplementary-material"}). Using PNOC-EGFP mice ([@bib59]), we identified PNOC-expressing cells in the ARC, the lateral hypothalamus (LHA), the dorsomedial nucleus of the hypothalamus (DMH), and the zona incerta ([Figure 1](#fig1){ref-type="fig"}D).Figure 1PNOC^ARC^ Neurons Are Activated upon Short-Term HFD Feeding(A) RNA sequencing (RNA-seq) profiling of gene expression after 3 days of NCD or HFD feeding using phosphoribotrap. Fold enrichment (IP/input) for each condition is shown.(B) Fold enrichment in IP/input HFD versus IP/input NCD and statistical significance are shown.(C) *Pnoc* mRNA fold expression (IP/input) and *Pnoc* mRNA expression (IP) for NCD-fed (n = 3) and HFD-fed (n = 4) mice.(D) Hypothalamic Pnoc expression in PNOC-EGFP mice.(E) Quantification of pS6 expression in PNOC^ARC^ neurons in PNOC-EGFP mice after 3 days of NCD or HFD (n = 4/4) feeding.(F) Representative pS6 stainings of the ARC of PNOC-eGFP mice after 3 days of NCD or HFD feeding. Scale bar, 200 μm.(G) Representative traces of spontaneous firing from original recordings of PNOC^ARC^ neurons from NCD- and HFD-fed mice.(H) Action potential firing frequencies and percentage of spontaneously active and silent (\<0.5 Hz) PNOC^ARC^ neurons from NCD-fed (n = 88) and HFD-fed (n = 28) mice. Empty and filled bars represent active and silent cells, respectively. Absolute numbers of neurons are indicated.(I) Input resistance of PNOC^ARC^ neurons from NCD-fed (n = 50) and HFD-fed (n = 24) mice.(J) Representative traces illustrating the application of a ramp stimulus protocol to assess excitability in PNOC^ARC^ neurons from NCD-fed and HFD-fed mice.(K) Threshold current determined by the ramp protocols in (J) of PNOC^ARC^ neurons from NCD-fed (n = 36) and HFD-fed (n = 23) mice.(L) Total number of action potentials elicited upon ramp current injection in PNOC^ARC^ neurons from NCD-fed (n = 36) and HFD-fed (n = 23) mice.(M) Quantification of *Fos*-positive PNOC^ARC^ neurons (fasted: n = 4/4, refed: n = 5/5).(N) Quantification of *Fos*-positive AgRP neurons (fasted: n = 4/4, refed: n = 5/5).^∗^p \< 0.05, ^∗∗^p \< 0.01, and ^∗∗∗^p \< 0.001 as determined by Mann-Whitney test (H, left; I; and K), Fisher test (H, right), 2-tailed, unpaired Student's t test (C, E, and L), and mixed-effects analysis followed by Sidak's multiple comparisons test (M and N).See also [Figure S1 and Table S1](#mmc1){ref-type="supplementary-material"}.

Next, we performed a co-expression analysis of PNOC and pS6 expression via immunohistochemistry on hypothalamic sections of mice, which express EGFP under the regulatory elements of the *Pnoc* gene via bacterial artificial chromosome (BAC) transgenesis and had been exposed to NCD or HFD for 3 days. This analysis revealed an enhancement of the proportion of PNOC neurons exhibiting pS6 immunoreactivity, particularly in the ARC of mice that had been fed HFD for 3 days ([Figures 1](#fig1){ref-type="fig"}E and 1F).

Furthermore, we performed perforated patch-clamp recordings of identified and synaptically isolated PNOC^ARC^ neurons ([Figures 1](#fig1){ref-type="fig"}G and 1H). While 24% of PNOC^ARC^ neurons were completely silent in NCD-fed animals, the percentage of silent neurons was decreased to only 1% in HFD-fed animals ([Figure 1](#fig1){ref-type="fig"}H). In addition, PNOC^ARC^ neurons had a higher mean firing rate in HFD-fed animals compared to NCD-fed animals ([Figures 1](#fig1){ref-type="fig"}G and 1H). Acute HFD feeding failed to alter the membrane potential of PNOC^ARC^ neurons ([Figure S1](#mmc1){ref-type="supplementary-material"}D), but the higher firing rate was accompanied by a tendency of increased input resistance in PNOC^ARC^ neurons of HFD-fed animals ([Figure 1](#fig1){ref-type="fig"}I). When we applied a triangular depolarizing stimulus protocol and determined the action potential threshold by measuring the current at the peak of the first action potential ([Figure 1](#fig1){ref-type="fig"}J), we found a significant decrease in the threshold current in PNOC^ARC^ neurons of HFD-fed animals ([Figure 1](#fig1){ref-type="fig"}K). The number of action potentials elicited by depolarizing current ramps was significantly higher compared to NCD-fed animals ([Figure 1](#fig1){ref-type="fig"}L), due to a uniform increase in the number of action potentials during the ascending and descending parts of the protocol ([Figures S1](#mmc1){ref-type="supplementary-material"}E and S1F), strongly suggesting a general increase in excitability without altering activity-dependent mechanisms ([Figure S1](#mmc1){ref-type="supplementary-material"}G).

To further investigate whether acute HFD feeding could affect the activity pattern of PNOC^ARC^ neurons, we analyzed their activation upon food consumption via performing *in situ* hybridizations for *Pnoc*, *Agrp*, and *Fos* mRNA expression in the ARC of NCD- and HFD-fed mice that were fasted and refed. This analysis revealed that in NCD-fed mice, refeeding suppressed the activation of PNOC^ARC^ neurons ([Figures 1](#fig1){ref-type="fig"}M and [S1](#mmc1){ref-type="supplementary-material"}H). This refeeding-induced inhibition was completely abrogated in mice that had been exposed to HFD for 3 days ([Figures 1](#fig1){ref-type="fig"}M and [S1](#mmc1){ref-type="supplementary-material"}H). In contrast, while refeeding potently suppressed fasting-induced activation of AgRP neurons in NCD-fed mice, short-term fasting-induced activation of AgRP neurons was largely reduced in animals exposed to HFD and not further suppressed upon refeeding ([Figures 1](#fig1){ref-type="fig"}N and [S1](#mmc1){ref-type="supplementary-material"}H). These experiments indicate that PNOC^ARC^ neurons lose their ability to rapidly adapt to the short-term increase in highly palatable caloric intake.

PNOC^ARC^ Neurons Are GABAergic and Distinct from POMC or AgRP Neurons {#sec2.2}
----------------------------------------------------------------------

To further characterize PNOC neurons on a molecular level, we performed BAC-TRAP (translating ribosome affinity purification)-based ribosome profiling of these cells in mice, which express a fusion protein of the ribosomal L10a protein with EGFP (L10a-EGFP) under control of the *Pnoc* promoter ([@bib21]). The precipitation of ribosomes of hypothalamic PNOC neurons with anti-GFP antibodies and subsequent sequencing of associated mRNAs allowed for the assessment of an in-depth translational profile of these cells. Besides a clear enrichment of *Pnoc* mRNA ([Figure 2](#fig2){ref-type="fig"}A), pathway analysis of enriched mRNAs revealed a signature of GABAergic neurons ([Figures 2](#fig2){ref-type="fig"}B and [S2](#mmc1){ref-type="supplementary-material"}A), while precipitation of *Agrp* mRNA was underrepresented in the pull-down ([Figure 2](#fig2){ref-type="fig"}A). Similarly, we found enrichment of *Pomc* mRNA in the hypothalamic, non-PNOC fraction ([Figure 2](#fig2){ref-type="fig"}A). These data indicate that PNOC^ARC^ neurons, AgRPs, and POMC neurons are distinct neuronal populations.Figure 2PNOC^ARC^ Neurons Are GABAergic and Distinct from POMC or AgRP Neurons(A) RNA-seq profiling of hypothalamic tissue of PNOC-L10a-EGFP mice using BAC-TRAP. Fold enrichment in IP/input (x axis) and statistical significance (y axis) are shown (NCD-fed mice).(B) Expression profiling of GABAergic marker genes in PNOC neurons using BAC-TRAP.(C) Overlap of Pnoc mRNA with neuronal clusters obtained from single-cell RNA-seq of ARC neurons ([@bib10]).(D) Representative confocal images and quantification of *in situ* hybridization of mRNA of *Pnoc* (cyan) and *Slc32a1* (gray) in the ARC of C57BL/6N mice (n = 4). Scale bar, 200 μm.(E) Representative confocal images and quantification of *in situ* hybridization of mRNA of *Pnoc* (cyan), *Agrp* (yellow), and *Pomc* (magenta) in the ARC of C57BL/6N mice (n = 5 for *Agrp* quantification, n = 6 for *Pomc* quantification). Scale bar, 200 μm.(F) Representative confocal images and quantification of *in situ* hybridization of mRNA of Pnoc (cyan) and Th (blue) in the ARC of C57BL/6N mice (n = 4). Scale bar, 200 μm.(G) Original traces illustrating inward rectification of a PNOC^ARC^ neuron upon hyperpolarizing current injections.(H) Quantification of inward rectification to 5 consecutive stimuli as illustrated by the non-linear relationship (solid red line) compared to a theoretical linear ohmic relationship (dashed black line).(I) Original examples of hyperpolarizations illustrating the inward rectification in PNOC^ARC^ and the lack of inward rectification in POMC and AgRP neurons.(J) Percentage of neurons with inward rectification upon hyperpolarization in PNOC^ARC^ (n = 28), POMC (n = 27), and AgRP neurons (n = 14) of NCD-fed mice.See also [Figure S2](#mmc1){ref-type="supplementary-material"}.

We next assessed the overlap of genes enriched in PNOC neurons as identified in the BAC-TRAP approach with data obtained from single-cell RNA sequencing of \> 20,000 arcuate and median eminence cells ([@bib10]). This analysis revealed a clear enrichment of PNOC neuron characteristic transcripts in a cluster of ARC neurons characterized by *Htr3b* expression ([Figure 2](#fig2){ref-type="fig"}C).

When we performed double *in situ* hybridizations with probes for *Pnoc* and either *Pomc*, *Agrp*, *Slc32a1* (VGAT), or *Th* (tyrosine hydroxylase) mRNA in the ARC, we confirmed that the majority (76.5%) of PNOC^ARC^ neurons express VGAT ([Figure 2](#fig2){ref-type="fig"}D). Furthermore, there was little overlap of *Pnoc* mRNA expression with *Agrp*- (10.1%), *Pomc*- (11.0%), or *Th-* (15.4%) mRNA expression ([Figures 2](#fig2){ref-type="fig"}E and 2F).

Electrophysiological recordings of PNOC^ARC^ revealed the presence of inward rectification upon hyperpolarizing stimuli ([Figures 2](#fig2){ref-type="fig"}G--2I). Hyperpolarizing current injections revealed inward rectification in \~82% of the recorded PNOC^ARC^ neurons ([Figure 2](#fig2){ref-type="fig"}J), while inward rectification upon hyperpolarizing current injections was only observed in \~14% of POMC and \~15% of AgRP neurons ([Figures 2](#fig2){ref-type="fig"}I and 2J). These studies suggest that PNOC^ARC^ neurons represent a GABAergic population that is distinct from previously characterized ARC neurons.

PNOC^ARC^ Neurons Are Regulated by Extracellular Glucose {#sec2.3}
--------------------------------------------------------

We next aimed to investigate the response of these cells to nutrients and circulating adiposity signals such as glucose and leptin. Therefore, we performed long-lasting perforated patch-clamp recordings from identified PNOC^ARC^ neurons combined with pharmacological experiments. To this end, we decreased extracellular glucose concentrations during electrophysiological recordings stepwise from 5 to 0.1 mM. Reduction of extracellular glucose concentrations profoundly hyperpolarized the membrane potential of PNOC^ARC^ neurons and led to significantly reduced firing of these neurons, thus characterizing them as glucose excited (GE)-ARC neurons ([Figures 3](#fig3){ref-type="fig"}A--3C). Altering extracellular glucose concentrations stepwise from 5 to 0.1 mM revealed a clear concentration-dependent inhibition of PNOC^ARC^ neurons ([Figure 3](#fig3){ref-type="fig"}B), similar to other GE neurons in the ARC ([@bib14]). In support of these findings, BAC-TRAP-based ribosome profiling revealed that hypothalamic PNOC neurons express functional K~ATP~ channels, specifically Kir6.2 (*Kcnj11*) and SUR1 (*Abcc8*) subunits ([Figure S3](#mmc1){ref-type="supplementary-material"}A). Furthermore, these neurons express glucokinase (*Gck*), a primary glucose sensor ([@bib46]), as well as transient receptor potential canonical type 3 (*Trpc3*) channels, which are involved in hypothalamic glucose detection ([@bib12]; [Figure S3](#mmc1){ref-type="supplementary-material"}A).Figure 3PNOC^ARC^ Neurons Are Regulated by Extracellular Glucose(A) Original recording and corresponding rate histogram of a PNOC^ARC^ neuron from a NCD-fed mouse treated with a decreased concentration of extracellular glucose (5--0.1 mM). Numbered arrows mark the sections of the recording that are displayed in a higher time resolution.(B) Normalized frequency and absolute membrane potential (inset) of PNOC^ARC^ neurons, illustrating a concentration-response relationship and responses to extracellular glucose concentrations ranging from 5 to 0.1 mM. The representative recordings and corresponding rate histograms illustrate the responses to 3, 1.5, and 0.1 mM, respectively. The numbers above the circles represent the number of experiments.(C) Membrane potential under control (5 mM) and low glucose (0.1 mM) conditions of PNOC^ARC^ neurons of NCD-fed mice (dashed black lines mark single experiments; n = 13).(D) Attenuated responsiveness to decreases in extracellular glucose to 0.1 mM. Original recording and corresponding rate histogram of a PNOC^ARC^ neuron from HFD-fed mice treated with decreased extracellular glucose (0.1 mM). Numbered arrows mark the sections of the recording that are displayed in higher time resolution.(E) Membrane potential under control (5 mM) and low glucose (0.1 mM) conditions of PNOC^ARC^ neurons of HFD-fed mice (dashed black lines mark single experiments; n = 23).(F) Mean change of the membrane potential upon treatment with low glucose in PNOC^ARC^ neurons of NCD-fed (n = 13) and HFD-fed mice (n = 23).(G) Original recording and corresponding rate histogram of a PNOC^ARC^ neuron treated with 100 nM leptin. Numbered arrows mark the sections of the recording that are displayed in a higher time resolution.(H) Effect of leptin treatment (100 nM) on action potential frequency of PNOC^ARC^ neurons.(I) Percentage of hyperpolarized, depolarized, and non-responsive neurons.^∗^p \< 0.05, ^∗∗^p \< 0.01, and ^∗∗∗^p \< 0.001 as determined by Mann-Whitney test (C and E), and 2-tailed, unpaired Student's t test (F) or by 2-tailed, paired Student's t test (H).See also [Figure S3](#mmc1){ref-type="supplementary-material"}.

We also performed similar electrophysiological studies in PNOC neurons in the LHA and in the bed nucleus of the stria terminalis (BNST). Here, also, the majority of PNOC^LHA^ neurons hyperpolarize their membrane potential upon the reduction of extracellular glucose concentrations ([Figures S3](#mmc1){ref-type="supplementary-material"}B--S3E). PNOC^BNST^ neurons exhibited a more heterogeneous response to changes in extracellular glucose concentrations ([Figures S3](#mmc1){ref-type="supplementary-material"}F--S3I). These experiments indicate that the majority of hypothalamic PNOC neurons represent glucose-excited neurons.

Since HFD feeding has been shown to impair neuronal glucose sensing in the ARC ([@bib50]), we tested whether short-term exposure to HFD also affects glucose sensitivity in PNOC^ARC^ neurons. While a number of neurons still responded to decreased extracellular glucose concentrations ([Figures 3](#fig3){ref-type="fig"}D and [S3](#mmc1){ref-type="supplementary-material"}J), we found a larger number of cells with attenuated or abrogated responsiveness to decreases in extracellular glucose ([Figures 3](#fig3){ref-type="fig"}D and 3E). The impaired glucose responsiveness in these cells revealed a significant decrease in the responsiveness to decreased extracellular glucose at the population level ([Figure 3](#fig3){ref-type="fig"}F), thus providing evidence for a relative activation of these cells in the presence of reduced glucose transport in response to acute HFD feeding ([@bib38]).

Since PNOC^ARC^ neurons respond to HFD feeding, we aimed to investigate a possible role of leptin signaling in the direct regulation of these neurons. Here, the application of 100 nM leptin to synaptically isolated, actively firing (\>0.5Hz) PNOC^ARC^ neurons on average decreased their activity. While the majority (80%) of PNOC^ARC^ neurons were inhibited, 1 neuron (10%) was activated by the application of leptin ([Figures 3](#fig3){ref-type="fig"}G--3I). *In situ* hybridization for *Lepr* expression in PNOC^ARC^ neurons revealed that 10% of these cells express the leptin receptor (*Lepr*) ([Figure S3](#mmc1){ref-type="supplementary-material"}K).

PNOC Signaling Mediates Acute Hyperphagia and Initial Body Weight Gain upon HFD Feeding {#sec2.4}
---------------------------------------------------------------------------------------

To specifically address the role of PNOC neurons in the regulation of food intake, we generated a PNOC-Cre mouse line, which expresses the Cre-recombinase from the *Pnoc* locus while simultaneously disrupting the *Pnoc* coding exon 2 via homologous recombination-based gene targeting in embryonic stem cells (ESCs) ([Figures 4](#fig4){ref-type="fig"}A and [S4](#mmc1){ref-type="supplementary-material"}A). PNOC-Cre mice exhibited the expected pattern of Cre-recombination as evidenced via overlap of endogenous *Pnoc* expression and ZsGreen fluorescence in mice expressing ZsGreen in a Cre-dependent manner ([Figure 4](#fig4){ref-type="fig"}B). As mice homozygous for the Cre allele lack the *Pnoc* gene product, breeding this mouse line to homozygosity allowed us to study the effects of global PNOC inactivation on body weight regulation.Figure 4PNOC Signaling Mediates Acute Hyperphagia and Initial Body Weight Gain upon HFD Feeding(A) Schematic diagram of the PNOC-Cre allele.(B) Representative confocal images of *in situ* hybridization of mRNA of *Pnoc* (cyan), endogenous Cre-driven ZsGreen fluorescence (yellow), and *Agrp* mRNA (cyan) in the ARC of PNOC-Cre::ZsGreen floxed mice. Scale bar, 200 μm.(C) Body weights of PNOC-Cre mice (PNOC-Cre^wt/wt^, PNOC-Cre^tg/wt^, and PNOC-Cre^tg/tg^) during HFD feeding (n = 15/12/9, 2-way repeated measures \[RM\] ANOVA with Sidak's multiple comparisons test).(D) Percentage of weekly body weight gain on HFD compared to Pnoc wild-type (WT) mice (n = 15/12/9, 2-way RM ANOVA followed by Sidak's multiple comparisons test).(E) Cumulative food intake on NCD.(F) Total food intake on NCD. (n = 5/5/5, 1-way ANOVA followed by Tukey's post hoc test).(G) Cumulative food intake during 3 days of HFD feeding.(H) Total food intake during 3 days of HFD feeding (n = 5/5/5, 1-way ANOVA followed by Tukey's post hoc test).(I) Cumulative food intake after 4 weeks on HFD.(J) Total food intake after 4 weeks of HFD feeding (n = 5/5/5, 1-way ANOVA followed by Tukey's post hoc test).(K) Fat mass of Pnoc WT, Pnoc HET and Pnoc KO mice after 4 weeks of HFD (n = 6/5/6, 1-way ANOVA followed by Tukey's post hoc test).(L) Representative images of computed tomography (CT) scans of Pnoc WT, Pnoc HET, and Pnoc KO mice after 4 weeks of HFD. Yellow, fat tissue; blue, non-adipose soft tissue.^∗^p \< 0.05, ^∗∗^p \< 0.01, and ^∗∗∗^p \< 0.001.See also [Figure S4](#mmc1){ref-type="supplementary-material"}.

While the body weight of Pnoc knockout (KO) mice on NCD did not significantly differ from control animals, they showed a clear reduction in body weight gain after 1 week of HFD feeding ([Figures 4](#fig4){ref-type="fig"}C, 4D, and [S4](#mmc1){ref-type="supplementary-material"}B). This initial difference in body weight gain decreased over time ([Figure 4](#fig4){ref-type="fig"}D). Similarly, food intake did not differ between control and Pnoc KO mice when exposed to NCD ([Figures 4](#fig4){ref-type="fig"}E and 4F), while it was significantly decreased in Pnoc KO mice compared to controls during the first 3 days of HFD feeding ([Figures 4](#fig4){ref-type="fig"}G and 4H). However, after 4 weeks of HFD feeding, no difference in food intake was observable ([Figures 4](#fig4){ref-type="fig"}I and 4J). Notably, this initial reduction in HFD intake resulted in decreased fat mass after 4 weeks of HFD feeding ([Figures 4](#fig4){ref-type="fig"}K, 4L, and [S4](#mmc1){ref-type="supplementary-material"}C). Pnoc KO mice also showed a trend toward increased water consumption ([Figures S4](#mmc1){ref-type="supplementary-material"}D--S4F). In addition, we found unaltered respiratory exchange ratio (RER) and locomotor activity between the groups of mice ([Figures S4](#mmc1){ref-type="supplementary-material"}G--S4L).

PNOC^ARC^ Neurons Densely Innervate the ARC {#sec2.5}
-------------------------------------------

We next investigated the projection pattern of PNOC^ARC^ neurons and compared it to that of AgRP and POMC neurons. PNOC-Cre, AgRP-Cre, and POMC-Cre mice were stereotaxically injected in the ARC with an adeno-associated virus (AAV) allowing for Cre-dependent expression of channelrhodopsin-2 (ChR2) fused to mCherry (AAV-DIO-ChR2-mCherry) ([Figure 5](#fig5){ref-type="fig"}A). Assessment of the distribution of mCherry-positive PNOC^ARC^ fibers revealed dense local arborizations within the ARC ([Figure 5](#fig5){ref-type="fig"}A). The dense PNOC^ARC^ fibers within the ARC largely overlapped with the localization of POMC neuron cell bodies, but not with AgRP neurons ([Figure 5](#fig5){ref-type="fig"}A). Moreover, we observed PNOC^ARC^ projections to other brain areas, including the BNST, similar to what was observed for AgRP and POMC fibers ([Figure 5](#fig5){ref-type="fig"}A). In contrast, while both AgRP and POMC neurons densely innervate the paraventricular nucleus of the hypothalamus (PVN), we did not detect PVN-projecting PNOC^ARC^ fibers ([Figure 5](#fig5){ref-type="fig"}A). Moreover, while AgRP and POMC neurons more densely innervate the LHA and dorsal raphe nucleus (DR), there were less prominent projections of PNOC^ARC^ neurons detectable in these regions ([Figure 5](#fig5){ref-type="fig"}A).Figure 5PNOC^ARC^ Neurons Densely Innervate the ARC and Monosynaptically Inhibit POMC Neurons(A) Injection of AAV-ChR2-mCherry into the ARC. Cre-dependent ChR2 expression in neuronal projections (ChR2-mCherry) of PNOC-Cre, Agrp-Cre, and Pomc-Cre mice (n = 4). (a) ARC, (b) anterior bed nucleus of the stria terminals (BNST), (c) paraventricular nucleus of the hypothalamus (PVN), (d) lateral hypothalamic area (LHA)/dorsal premammillary nucleus (PMD), and (e) dorsal raphe nucleus (DR). Scale bar, 200 μm.(B) Schematic (left) and representative traces of light-evoked IPSCs recorded from POMC neurons in PNOC-Cre::POMC-IRES-EGFP mice expressing ChR2 in PNOC^ARC^ neurons (n = 12).(C) Schematic (top) and representative traces of sIPSCs recorded from POMC neurons in POMC-IRES-EGFP mice.(D and E) Frequency (D) and amplitude (E) of sIPSCs in POMC neurons from NCD-fed (n = 18) or HFD-fed (n = 21) mice.^∗^p \< 0.05, ^∗∗^p \< 0.01, and ^∗∗∗^p \< 0.001 as determined by 2-tailed, unpaired Student's t test.See also [Figure S5](#mmc1){ref-type="supplementary-material"}.

To investigate the downstream effects of activating PNOC^ARC^ neurons, we used positron emission tomography (PET) coupled with photostimulation of PNOC^ARC^ neurons in anesthetized mice. This allowed us to measure changes in regional brain glucose metabolism in response to acute photostimulation. We found reduced glucose metabolism in the BNST and in the amygdala and other feeding regulatory centers, such as the LHA ([@bib57]), zona incerta ([@bib74]), and the lateral septum ([@bib62]; [Figures S5](#mmc1){ref-type="supplementary-material"}A and S5B) in response to the activation of PNOC^ARC^ neurons, indicating the inhibition of neuronal activity in feeding-regulatory projection sites, including the BNST, which receives prominent projections from these cells.

PNOC^ARC^ Neurons Monosynaptically Inhibit POMC Neurons {#sec2.6}
-------------------------------------------------------

Since PNOC^ARC^ neurons form local innervation in the ARC overlapping with the localization of POMC neurons ([Figure 5](#fig5){ref-type="fig"}A) and GABAergic tone regulates POMC neuron activity ([@bib20], [@bib47], [@bib69]), we determined whether PNOC^ARC^ neurons provide direct inhibitory input into anorexigenic POMC neurons. To probe local connectivity between PNOC^ARC^ and POMC neurons, we performed ChR2-assisted circuit mapping (CRACM; [@bib1], [@bib52]). To this end, we injected AAV-DIO-ChR2-mCherry into the ARC of PNOC-Cre::POMC-IRES-EGFP mice ([Figure S5](#mmc1){ref-type="supplementary-material"}C) and recorded light-evoked inhibitory postsynaptic currents (IPSCs) in POMC neurons ([Figure 5](#fig5){ref-type="fig"}B). We readily detected robust light-evoked IPSCs in all (12 of 12) of the POMC neurons tested ([Figure 5](#fig5){ref-type="fig"}B). The light-evoked IPSCs were completely blocked by bath application of the GABA~A~-receptor antagonist bicuculline ([Figure 5](#fig5){ref-type="fig"}B). Thus, PNOC^ARC^ neurons synaptically release GABA onto POMC neurons in the ARC. Since acute HFD feeding robustly increased the activity and excitability of PNOC^ARC^ neurons ([Figure 1](#fig1){ref-type="fig"}), we investigated whether GABAergic input to POMC neurons is affected upon HFD feeding. Three days of HFD feeding markedly increased both the frequency and the amplitude of spontaneous GABAergic IPSCs (sIPSCs) in POMC neurons ([Figures 5](#fig5){ref-type="fig"}C--5E). Thus, short-term HFD feeding caused a marked increase in GABAergic tone onto POMC neurons paralleled by the activation of PNOC^ARC^ neurons, which provides strong GABAergic input onto POMC neurons.

Optogenetic PNOC^ARC^ Neuron Activation Promotes Feeding {#sec2.7}
--------------------------------------------------------

To investigate the functional role of PNOC^ARC^ neurons in feeding regulation, we crossed PNOC-Cre mice with animals, allowing for Cre-dependent expression of the excitatory opsin ChR2. Optical fibers were implanted above the ARC of PNOC-Cre ChR2-positive mice to selectively photostimulate PNOC^ARC^ neurons ([Figure S6](#mmc1){ref-type="supplementary-material"}A). Blue light illumination at the onset of the dark phase and during daytime increased NCD food intake in PNOC-Cre ChR2-positive mice ([Figures 6](#fig6){ref-type="fig"}A, 6B, [S6](#mmc1){ref-type="supplementary-material"}B, and S6C) concomitant with a significant shift in RER and an increase in water intake ([Figures S6](#mmc1){ref-type="supplementary-material"}D--S6F). In contrast, in the absence of photostimulation, food intake and water consumption did not differ between the two groups of mice ([Figures 6](#fig6){ref-type="fig"}C, 6D, [S6](#mmc1){ref-type="supplementary-material"}G, and S6H). In contrast, when we stimulated PNOC^ARC^ neurons in fasted mice, PNOC^ARC^ neuron activation failed to alter water intake ([Figures S6](#mmc1){ref-type="supplementary-material"}I and S6J). Moreover, photostimulation of PNOC^ARC^ neurons increased HFD intake alongside a shift in RER ([Figures 6](#fig6){ref-type="fig"}E, 6F, and [S6](#mmc1){ref-type="supplementary-material"}K). Again, in the absence of laser stimulation, food intake did not differ between the two groups of mice ([Figures 6](#fig6){ref-type="fig"}G and 6H).Figure 6Optogenetic PNOC^ARC^ Neuron Activation Promotes FeedingData are plotted as cumulative food intake over time and total food intake after the stimulation period (16 h).(A) Cumulative food intake with photostimulation on NCD (n = 12/11).(B) Total food intake on NCD.(C) Cumulative food intake without photostimulation on NCD (n = 12/11).(D) Total food intake without photostimulation on NCD.(E) Cumulative food intake with photostimulation after 3 days of HFD feeding (n = 11/11).(F) Total food intake (3 days of HFD feeding).(G) Cumulative food intake without stimulation after 2 days of HFD feeding (n = 11/11).(H) Total food intake without stimulation (2 days of HFD feeding).(I) Cumulative food intake with photostimulation of PNOC^ARC^-LHA projections (NCD, n = 6/7).(J) Total food intake (PNOC^ARC^-LHA projections).(K) Cumulative food intake without photostimulation of PNOC^ARC^-LHA projections (n = 6/7).(L) Total food intake without photostimulation (PNOC^ARC^-LHA projections).(M) Cumulative food intake with photostimulation of PNOC^ARC^-BNST projections (NCD, n = 6/7).(N) Total food intake (PNOC^ARC^-BNST projections).(O) Cumulative food intake without photostimulation of PNOC^ARC^-BNST projections (n = 6/7).(P) Total food intake without photostimulation (PNOC^ARC^-BNST projections).^∗^p \< 0.05, ^∗∗^p \< 0.01, and ^∗∗∗^p \< 0.001 as determined by 2-tailed, unpaired Student's t test.See also [Figure S6](#mmc1){ref-type="supplementary-material"}.

Since the activation of food intake-stimulating AgRP neurons had been demonstrated to act as a negative valence teaching signal ([@bib6]), we performed photostimulation of PNOC^ARC^ neurons in a place-preference/aversion setup. However, the activation of PNOC^ARC^ cells failed to induce aversive or appetitive behavior either upon acute stimulation or repeated conditioning ([Figures S6](#mmc1){ref-type="supplementary-material"}L and S6M). Furthermore, upon photostimulation of PNOC^ARC^ neurons, no acute effects on glucose homeostasis or insulin sensitivity were observed ([Figures S6](#mmc1){ref-type="supplementary-material"}N and S6O).

Because PNOC neurons project locally within the ARC and to other brain regions, we aimed at investigating the potential contribution of PNOC^ARC^ → LHA and PNOC^ARC^ → BNST projections in mediating the food intake-stimulatory effect of optogenetic PNOC^ARC^ neuron activation. To this end, we injected AAV-DIO-ChR2-EYFP (enhanced yellow fluorescent protein) into the ARC of PNOC-Cre mice ([Figure S6](#mmc1){ref-type="supplementary-material"}P) and implanted optical fibers either above the LHA or the BNST ([Figures S6](#mmc1){ref-type="supplementary-material"}Q and S6R). While photostimulation of PNOC^ARC^ → LHA fibers had no effect on food intake ([Figures 6](#fig6){ref-type="fig"}I--6L), the stimulation of PNOC^ARC^ → BNST projections potently increased food intake ([Figures 6](#fig6){ref-type="fig"}M--6P)

The activation of PNOC^ARC^ neurons increases feeding, and while these neurons provide inhibitory input on anorexigenic POMC neurons within the ARC, part of this effect is mediated through PNOC^ARC^ → BNST projections.

Ablation of PNOC^ARC^ Neurons Protects from HFD-Induced Obesity {#sec2.8}
---------------------------------------------------------------

To investigate the necessity of PNOC^ARC^ neurons in feeding regulation, we bilaterally injected PNOC-Cre or wild-type littermate control animals with an AAV, allowing for Cre-dependent expression of activated caspase-3 (AAV^Casp^) in the ARC to selectively ablate PNOC^ARC^ neurons ([Figures 7](#fig7){ref-type="fig"}A and [S7](#mmc1){ref-type="supplementary-material"}A). Assessment of *Pnoc* mRNA expression via *in situ* hybridization revealed the expected reduction of PNOC expression in the ARC of PNOC-Cre mice, but not in control animals ([Figures 7](#fig7){ref-type="fig"}B and [S7](#mmc1){ref-type="supplementary-material"}B). Expression of *Pomc* mRNA in the ARC was unchanged between the groups ([Figure S7](#mmc1){ref-type="supplementary-material"}C). Three weeks following viral injection, a cohort of mice was exposed to HFD feeding. Body weight and food intake between AAV^Casp^-injected PNOC-Cre mice compared to AAV^Casp^-injected control animals did not differ 2 weeks following virus injection upon NCD feeding ([Figures 7](#fig7){ref-type="fig"}C, [S7](#mmc1){ref-type="supplementary-material"}D, and S7E). When we then switched the animals from NCD to HFD, AAV^Casp^-injected PNOC-Cre mice exhibited a reduced body weight gain as compared to AAV^Casp^-injected control animals ([Figure 7](#fig7){ref-type="fig"}C). After 3 days of HFD feeding, we found a significant reduction in food intake ([Figures 7](#fig7){ref-type="fig"}D--7G). Here, we also found a significantly increased caloric intake for the AAV^Casp^-injected control animals on acute HFD compared to their previous NCD intake, whereas this acute overeating was abrogated in the AAV^Casp^-injected PNOC-Cre mice ([Figures 7](#fig7){ref-type="fig"}F and 7G). After 5 weeks of HFD feeding, the AAV^Casp^-injected PNOC-Cre mice showed significantly reduced body weights ([Figure 7](#fig7){ref-type="fig"}C) and a trend toward reduced adiposity ([Figures 7](#fig7){ref-type="fig"}H and 7I). Furthermore, we found significantly reduced food intake even after 5 weeks of HFD feeding ([Figures S7](#mmc1){ref-type="supplementary-material"}F and [S7](#mmc1){ref-type="supplementary-material"}G). In a separate cohort, AAV^Casp^-injected PNOC-Cre mice and control animals remained on NCD. Here, the animals showed no difference in body weight ([Figure 7](#fig7){ref-type="fig"}J). When we compared the activation of POMC neurons, the ablation of PNOC^ARC^ neurons clearly increased the proportion of Fos-expressing POMC neurons in HFD-fed mice compared to control mice on the same diet ([Figure 7](#fig7){ref-type="fig"}K). Quantification of PNOC expressing cells showed a significant positive correlation with the number of PNOC neurons in the ARC and body weight gain on HFD ([Figures 7](#fig7){ref-type="fig"}L and [S7](#mmc1){ref-type="supplementary-material"}H).Figure 7Ablation of PNOC^ARC^ Neurons Protects from HFD-Induced Obesity(A) Injection of AAV-flex-taCasp3-TEVp into the ARC of PNOC-Cre and littermate WT control animals.(B) Representative confocal images of *in situ* hybridization of *Pnoc* mRNA (green) and DAPI staining (blue). Scale bar, 200 μm.(C) Body weight of PNOC^ARC^ ablated mice. Mice were fed an HFD after 3 weeks postsurgery (n = 10/9).(D) Cumulative food intake during 3 days of HFD feeding (n = 8/9).(E) Total food intake after 3 days of HFD feeding (n = 8/9).(F) Food intake of AAVCasp-injected control animals on NCD and after 3 days of HFD feeding (n = 8/9).(G) Food intake of AAVCasp-injected PNOC-Cre mice on NCD and after 3 days of HFD feeding (n = 8/9).(H) Representative images of CT scans of AAVCasp-injected PNOC-Cre mice and control animals after 5 weeks of HFD. Yellow, fat tissue; blue, non-adipose soft tissue.(I) Fat mass of AAVCasp-injected PNOC-Cre mice and control animals after 5 weeks of HFD (n = 6/5).(J) Body weight of PNOC^ARC^ ablated mice. Mice were fed a NCD postsurgery (n = 9/8).(K) Quantification of *Fos*-positive POMC neurons after 5 weeks of HFD feeding (n = 10/9).(L) Correlation of body weight gain during 5 weeks of HFD feeding and the average number of Pnoc neurons per section and hemisphere (Pearson correlation is reported, n = 10/9).^∗^p \< 0.05, ^∗∗^p \< 0.01, and ^∗∗∗^p \< 0.001 as determined by 2-way RM ANOVA with Sidak's multiple comparisons test (C and J), by 2-tailed, unpaired Student's t test (E--G, I, and K). To assess the correlation between 2 variables, Pearson's correlation coefficient for normally distributed data was used (L).See also [Figure S7](#mmc1){ref-type="supplementary-material"}.

Discussion {#sec3}
==========

Deterioration of energy homeostasis initiated by the consumption of highly palatable, calorie-dense food represents a key step in the development of obesity. Here, we demonstrate that the consummatory aspect of palatable food is regulated via a newly identified population of PNOC neurons in the ARC. This finding is in line with the recent identification of PNOC neurons in the central amygdala (CeA), which are activated by palatable food consumption ([@bib30]). However, in contrast to the results obtained in our study, the activation of PNOC cell bodies in the CeA or their axons in the ventral BNST, parabrachial nucleus (PBN), and nucleus of the solitary tract (NTS) induces reward behavior but failed to promote the feeding of palatable food ([@bib30]). Thus, PNOC neurons appear to be activated at different sites in the CNS to control distinct aspects of HFD-induced hyperphagia (i.e., increased food consumption via PNOC^ARC^ neurons and increased food-associated reward as controlled via PNOC neurons in the CeA).

Rodents placed on an HFD show a transient increase in food intake ([@bib64]). Using whole-body Pnoc KO mice, we find abrogation of acute hyperphagia and reduced body weight gain during the first week of HFD feeding. This indicates that Pnoc-expressing circuitries play key integrative roles in acute hyperphagia and the development of obesity. These findings are consistent with previous reports on attenuated HFD-binge eating behavior upon treatment with the selective nociceptin receptor (NOP) antagonist SB-612111 ([@bib29]) and reduced overconsumption of palatable high-energy diet upon treatment with the NOP antagonist LY2940094 ([@bib61]). In fat-preferring rats, intracerebroventricular (i.c.v.) administered nociceptin exhibited a hyperphagic response, whereas sucrose-preferring or "neutral" rats did not increase the intake of preferred diets ([@bib48]). Moreover, *icv* injection of nociceptin induced acute hyperphagia in satiated rats ([@bib53]), and more recently, it was shown that intra-ARC injections of nociceptin increased energy intake, which was further potentiated by exposure to HFD ([@bib34]). The latter finding is consistent with our observation that the optogenetic activation of PNOC^ARC^ neurons increases the intake of NCD and HFD.

Although we demonstrate through multiple complementary approaches that PNOC^ARC^ neurons are robustly activated upon short-term HFD feeding, the exact mechanism underlying this regulation clearly deserves future study. We show that PNOC^ARC^ neurons are strongly activated by rising extracellular glucose concentrations, and within 3 days of acute HFD feeding, a large proportion of these cells exhibits attenuated sensitivity to decreased extracellular glucose concentrations. Our previous studies revealed that short-term feeding of HFD during the same time range reduces brain glucose uptake via suppression of GLUT-1-expression in blood-brain barrier vascular endothelial cells ([@bib38]). Thus, an altered ability to reduce PNOC^ARC^ neuron firing in response to lowered extracellular glucose concentrations may lead to the excitation of these neurons under such conditions and thus promote their activity. Therefore, defining the molecular basis of altered glucose sensing under conditions in which glucose availability is reduced may point toward a new mechanistic basis of altered feeding circuit regulation in obesity. In addition, we reveal that a subset of PNOC neurons are inhibited by leptin. Direct leptin action on POMC and AgRP neurons was shown to play only a small role in controlling energy balance ([@bib67]). Our finding is in line with a report that shows that leptin, acting directly on presynaptic GABAergic neurons, many of which do not express AgRP, reduces inhibitory tone to postsynaptic POMC neurons ([@bib69]). Clearly, future studies must address the physiological diet-dependent regulation of PNOC^ARC^ neurons using *in vivo* calcium imaging.

We define PNOC^ARC^ neurons as a previously functionally uncharacterized class of feeding-regulatory neurons in the ARC. We further reveal a clear GABAergic signature of PNOC^ARC^ neurons and find a minor overlap of PNOC and POMC neurons (11.0%), which is in line with a report that showed a 13.9% overlap between PNOC and POMC neurons in the ARC ([@bib45]). Consequently, we define them as distinct from the well-characterized feeding-promoting *Agrp*- or *Th*-expressing cells in the ARC, also consistent with the notion that although AgRP neurons promote feeding upon chemogenetic or optogenetic activation, they are dispensable for an appropriate feeding response to palatable food ([@bib18]). In fact, our in-depth molecular profiling in conjunction with single-cell sequencing data define them as a class of ARC neurons characterized by *Htr3b* expression.

Previous work has shown the activation of AgRP neuron firing upon 2--6 days of short-term HFD feeding ([@bib71]). In this study, the authors demonstrate that while long-term HFD feeding abolishes the ability of leptin to inhibit AgRP neurons ([@bib4]), leptin still normally inhibits AgRP neuron firing upon short-term HFD feeding ([@bib71]). Consistent with this, AgRP and PNOC^ARC^ neurons are active in the fasting state of lean NCD-fed mice, and both types of neurons are inhibited upon 1 h of refeeding in NCD-fed mice. Here, the acute suppression of AgRP neurons is more profound compared to that of PNOC^ARC^ neurons as assessed via Fos expression. Remarkably, in 3 days HFD-fed mice, fasting-induced AgRP neuron activation is blunted, indicating that AgRP neurons are capable of sensing the energy state of the organism and adapt their activity during an early phase of HFD intake. This is also consistent with the study by [@bib71], revealing normal leptin sensitivity under these conditions. Nevertheless, PNOC^ARC^ neurons upon short-term HFD feeding retain their activity and lose their ability to suppress their activity upon refeeding. In addition, our phosphoribotrap approach failed to identify AgRP neurons as chronically activated upon 3 days of HFD feeding. Thus, although AgRP neurons can also increase their firing upon short-term HFD feeding, they apparently retain the ability to sense transitions in feeding state, while PNOC^ARC^ neurons lose their regulation and become activated upon short-term HFD feeding.

Regarding the downstream effector circuitry of feeding stimulation via activation by PNOC^ARC^ neurons, we find that the inhibition of POMC neurons is driven by direct monosynaptic GABAergic output of PNOC^ARC^ neurons. This finding is consistent with a clear enhancement of IPSCs on POMC neurons upon short-term HFD feeding. In contrast, AgRP neurons do not contribute a significant source of spontaneous GABA input to POMC neurons, which indicates that other GABAergic cells play an important role in spontaneous inhibitory modulation of POMC neurons ([@bib54]). In addition, a role for the NOP in the inhibition of POMC neuronal activity was reported. Bath application of nociceptin reversibly hyperpolarized and decreased firing in POMC neurons via a NOP-mediated mechanism ([@bib34]). Furthermore, nociceptin-induced presynaptic inhibition of glutamatergic input onto POMC neurons observed in wild-type mice was absent in NOP KO mice ([@bib22]). In addition to the PNOC^ARC^-dependent inhibition of POMC neurons, bath application of nociceptin potently suppressed activity in LepRb-expressing ventromedial hypothalamic (VMH) neurons ([@bib11]). Therefore, nociceptin acts as an orexigenic factor by suppressing VMH output, and future studies are warranted to investigate the link between PNOC^ARC^ and VMH neurons. The activation of POMC neurons is enhanced in mice with selective ablation of PNOC^ARC^ neurons upon HFD feeding, revealing the functional relevance of these cells in the control of POMC neuron function upon HFD feeding. In addition, our experiments reveal that PNOC^ARC^ → BNST projections also contribute to the feeding stimulatory effect of optogenetic PNOC^ARC^ neuron activation.

Our data reveal that PNOC^ARC^ neurons represent a neuronal population distinct from AgRP- and POMC-expressing cells, which is activated upon short-term HFD feeding, that these neurons provide strong inhibitory input on POMC neurons, and that upon photostimulation these cells also increase food intake via projections to the BNST. Selective ablation of these cells reduces feeding and body weight gain upon HFD feeding but not in NCD-fed mice. Thus, we define the PNOC^ARC^ neuronal signaling as a critical pathway underlying the instatement of hyperphagia upon short-term HFD feeding.

STAR★Methods {#sec4}
============

Key Resources Table {#sec4.1}
-------------------

REAGENT or RESOURCESOURCEIDENTIFIER**Antibodies**Phospho-S6 (Ser244, Ser247) Polyclonal AntibodyThermo Fisher ScientificCat\# 44-923G, RRID:[AB_2533798](nif-antibody:AB_2533798){#intref0010}Heintz Lab TRAP anti-GFP 19F7 antibodyHeintz Lab; Rockefeller University ([@bib32])Cat\# Htz-GFP-19F7, RRID:[AB_2716736](nif-antibody:AB_2716736){#intref0015}Heintz Lab TRAP anti-GFP 19C8 antibodyHeintz Lab; Rockefeller University ([@bib32])Cat\# Htz-GFP-19C8, RRID:[AB_2716737](nif-antibody:AB_2716737){#intref0020}Goat anti-Rabbit IgG (H+L) Cross-Adsorbed Secondary Antibody, Alexa Fluor 594Thermo Fisher ScientificCat\# A-11012, RRID:[AB_2534079](nif-antibody:AB_2534079){#intref0025}**Bacterial and Virus Strains**AAV-flex-taCasp3-TEVpUNC Vector core, plasmid a gift from Nirao ShahIn Stock AAV Vectors (plasmid: Addgene Cat\# 45580)pAAV-EF1a-double floxed-hChR2(H134R)-mCherry-WPRE-HGHpA (AAV1)Addgene, plasmid a gift from Karl DeisserothAddgene, Cat\# 20297-AAV1pAAV-EF1a-double floxed-hChR2(H134R)-EYFP-WPRE-HGHpA (AAV1)Addgene, plasmid a gift from Karl DeisserothAddgene, Cat\# 20298-AAV1**Chemicals, Peptides, and Recombinant Proteins**IgG-free BSASigma Aldrich/MerckCat\# A2058CycloheximideAppliChemCat\# A0879,[0001](mi:0001){#intref0030}Nonident P40AppliChemCat\# A1694,0250HEPESAppliChemCat\# A1069,0250KClSigma Aldrich/MerckCat\# P9541RNasinPromegaCat\# N2511DHPCAvanti Polar LipidsCat\# 850306PDTTAppliChemCat\# A1101,0005Complete Mini, EDTA-freeSigma Aldrich/MerckCat\# 11836170001PhosSTOP (Phosphatase Inhibitor Cocktail)Sigma Aldrich/MerckCat\# 04906845001LeptinSigma Aldrich/MerckCat\# L3772D-MannitolAppliChemCat\# A4831Amphotericin BSigma Aldrich/MerckCat\# A4888Bicuculline methiodideSigma Aldrich/MerckCat\# 14343PicrotoxinSigma Aldrich/MerckCat\# P1675DL-2-amino-5-phosphonopentanoic acid (DL-AP5)BiotrendCat\# BN00866-cyano-7-nitroquinoxaline-2,3-dione (CNQX)Sigma Aldrich/MerckCat\# C127**Critical Commercial Assays**RNAscope Multiplex Fluorescent Reagent Kit v2Advanced Cell DiagnosticsCat\# 323100Probe Mm-PnocAdvanced Cell DiagnosticsCat\# 437881Probe Mm-PomcAdvanced Cell DiagnosticsCat\# 314081Probe Mm-AgrpAdvanced Cell DiagnosticsCat\# 400711Probe Mm-Slc32a1Advanced Cell DiagnosticsCat\# 319191Probe Mm-ThAdvanced Cell DiagnosticsCat\# 317621Probe Mm-FosAdvanced Cell DiagnosticsCat\# 316921Probe Mm-LeprAdvanced Cell DiagnosticsCat\# 402731RNeasy Micro kitQIAGENCat\# 74004Agilent RNA 6000 Pico KitAgilentCat\# 5067-1513**Deposited Data**Phosphoribotrap RNA Seq raw and analyzed dataThis paperGSE137737PNOC BacTRAP RNA Seq raw and analyzed dataThis paperGSE137626Gene expression in 20,921 individual cells in and around the adult mouse Arc-ME using Drop-seq[@bib10]GSE90806**Experimental Models: Cell Lines**C57BL/6N-PRX-B6NJackson LaboratoryStock No: 012448ES-Bruce 4Dr. Frank KoentgenN/A**Experimental Models: Organisms/Strains**Mouse: C57BL/6NCharles River LaboratoriesStrain code: 027PNOC-CreThis paperN/APOMC-IRES-EGFPThis paperN/ATg(Pnoc-EGFP)\#UzeZeilhofer HU, University of Zurich ([@bib59])MGI:[5426015](mgi:5426015){#intref0035}Tg(Pnoc-EGFP/Rpl10a)GM64HtzZeilhofer HU, University of Zurich ([@bib21])MGI:[5496695](mgi:5496695){#intref0040}ROSA26loxSTOPloxChR2(H134R)-EYFP-WPREJackson Laboratory ([@bib44])Stock No: 012569, RRID:IMSR_JAX:012569POMC-CreJackson Laboratory ([@bib3])Stock No: 005965, RRID:IMSR_JAX:005965AgRP-IRES-EGFPJackson Laboratory ([@bib65])Stock No: 012899 RRID:IMSR_JAX:012899**Oligonucleotides**5screen5pnoc: CAGATTCTGTATCTATAATTTG\
ATGGATTTGGEurogentech GermanyN/A3Cre5screen: ATGTTTAGCTGGCCCAAATGTT\
GCTGGATAGTEurogentech GermanyN/A5screen5neo: GGGCCAGCTCATTCCTCCCAC\
TCATGATCTATAGAEurogentech GermanyN/A3screen3pnoc: GCTCAGTTCTCTGCTCCTTTG\
GTTTACTGGTGEurogentech GermanyN/A**Software and Algorithms**RThe R Foundation for Statistical Computing, Institute for Statistics and Mathematics, University of Economics and Business, Vienna, Austria<https://www.r-project.org>Halo Image Analysis PlatformIndica labs<https://www.indicalab.com/halo/>FijiImageJ/Fiji<https://fiji.sc/>Spike2Cambridge Electronic Design<http://ced.co.uk/>Igor Pro 6Wavemetrics<https://www.wavemetrics.com>PatchmasterHEKA<https://www.heka.com>pClamp/ClampfitMolecular Devices<https://www.moleculardevices.com/>GraphPad PrismGraphPad<https://www.graphpad.com/scientific-software/prism/>ExpeDataSable Systems<https://www.sablesys.com>VinciMax Planck Institute for Metabolism Research<https://vinci.sf.mpg.de/>**Other**Maintenance Diet (NCD)Ssniff SpezialdiätenCat\# R/M-HControl Diet (NCD)Ssniff SpezialdiätenCat\# EF D12450BHigh-Fat Diet (HFD)Ssniff SpezialdiätenCat\# EF D12492-(I)Protein A DynabeadsInvitrogenCat\# 10001SuperFrost Plus Gold slidesThermo FisherCat\# K5800AMNT72Vectashield Antifade Mounting Medium with DAPIVector LaboratoriesCat\# H-1200

Resource Availability {#sec4.2}
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### Lead Contact {#sec4.2.1}

Additional information and requests for resources or reagents used in this paper should be directed and will be fulfilled by the Lead Contact, Jens C. Brüning (<bruening@sf.mpg.de>).

### Materials Availability {#sec4.2.2}

Mouse lines generated in this study are available from the Lead Contact with a completed Materials Transfer Agreement.

### Data and Code Availability {#sec4.2.3}

Raw and fully processed RNA-Seq data from the phosphoribotrap screen are available at GEO accession number [GSE137737](ncbi-geo:GSE137737){#interref155}. Raw and fully processed RNA-Seq data from BacTRAP-based ribosomal profiling of PNOC neurons are available at GEO accession number [GSE137626](ncbi-geo:GSE137626){#intref0110}. All data and code are available upon reasonable request.

Experimental Model and Subject Details {#sec4.3}
--------------------------------------

### Animal Care {#sec4.3.1}

All animal procedures were conducted in compliance with protocols approved by local government authorities (Bezirksregierung Köln). Permission to maintain and breed mice was issued by the Department for Environment and Consumer Protection - Veterinary Section, Köln, North Rhine-Westphalia, Germany. All animal procedures were performed in accordance with NIH guidelines. Mice were housed in individually ventilated cages (IVCs) at 22°C--24°C using a 12-hour light/dark cycle. Animals had access to water and food *ad libitum*. Food was only withdrawn if required for an experiment during defined fasting periods. Sex is a significant modifier of the impact of HFD ([@bib36]), therefore all experiments have been performed in male mice (If not stated otherwise).

### Animal Diets {#sec4.3.2}

Mice had *ad libitum* access to either a normal chow-diet (R/M-H; Ssniff Diet) containing 57% of calories from carbohydrates, 34% calories from protein and 9% calories from fat, a control-diet (NCD; EF D12450B; Ssniff Diet) containing 67% of calories from carbohydrates, 20% of calories from protein and 13% of calories from fat, or a high-fat diet (HFD; EF D12492-(I); Ssniff Diet) containing 21% calories from carbohydrates, 19% calories from protein and 60% calories from fat. Fasting/refeeding experiments: 8-week-old male C57BL/6N mice were obtained from Charles River, France and acclimatized to the facility for 14 days prior to the experiment. Fasting cohorts were fasted for 8 hours (after being fed either NCD or HFD for 3 days). Refeeding cohorts were fasted for 8 hours (after being fed either NCD or HFD for 3 days) and refed for 1 hour with their respective diet.

### Mouse lines {#sec4.3.3}

C57BL/6N - This mouse line was obtained from Charles River, France.

BAC-transgenic PNOC-eGFP (B6.FVB-Tg(pnoc-EGFP)Uze, MGI:[5426015](mgi:5426015){#intref0115}) carrying a eGFP expression cassette introduced into the start codon of BAC RPCI 452H11 were used for electrophysiology experiments.

PNOC-L10a-eGFP (Tg(Pnoc-EGFP/Rpl10a)GM64Htz, MGI:[5496695](mgi:5496695){#intref0120}) mice were used for BacTRAP experiments.

For experiments enabling photostimulation of PNOC neurons, mice homozygous for a ROSA26loxSTOPloxChR2(H134R)-EYFP-WPRE conditional allele were bred to PNOC-Cre mice and the resulting Pnoc^tg/wt^::ChR2^fl/wt^ (Pnoc ChR2) and Pnoc^wt/wt^::ChR2^fl/wt^ (control) mice were used for experiments. ROSA26loxSTOPloxChR2(H134R)-EYFP-WPRE) ([@bib44]) with a conditional allele (Ai32) were obtained from Jackson Laboratory (stock\# 012569).

For CRACM experiments, PNOC-Cre mice were crossed with POMC-IRES-eGFP mice (see '[Generation of POMC-IRES-eGFP Mice](#sec4.4.2){ref-type="sec"}').

POMC-Cre - This line has previously been described ([@bib3]) and was obtained from Jackson Laboratory (stock\# 005965). Mice were bred to C57BL/6N mice from Charles River, France, to maintain the line in the facility of the Max Planck Institute for Metabolism Research, Cologne, Germany.

AgRP-IRES-Cre - This line has previously been described ([@bib65]). Mice were bred to C57BL/6N mice from Charles River, France, to maintain the line in the facility of the Max Planck Institute for Metabolism Research, Cologne, Germany.

Method Details {#sec4.4}
--------------

### Generation of PNOC-Cre mice {#sec4.4.1}

To generate PNOC-Cre knock in mice, a targeting vector was designed that replaces exon 2, containing the ATG translation start-site of Pnoc, with Cre. To this end TW1 plasmid containing Cre and neo/kana resistance cassette was used to insert PCR amplified left arm of homology (LAH) and right arm of homology (RAH). 2576 bp LAH was amplified from B6Ng01-327O03 BAC using oligos 5KpnLAHpnoc: GGTACCGCGATCGCAGAGGGCTGGAGAGTTATCTCA and 3SalLAHpnoc: GTCGACGCAGCAGTGGGAATCGGGAG. Subsequently, LAH was cloned into TW1 via Kpn1/Sal1 digest. Furthermore, 4.7 kb RAH was amplified from B6Ng01-327O03 BAC using oligos 5AscRAHpnoc: GGCGCGCCAAAATCCTCTTTTGTGACGTTCTG and 3SacIIRAHpnoc: CCGCGGAAGAGATAAGTCTAGAGGCCACT and inserted into LAH containing TW1 plasmid via Asc1/SacII digest. 30μg of Pnoc targeting vector was transfected into 107 Bruce 4 ES cells that upon G418 selection were screened by long range PCR for correct integration using 5′ screening of 3.11 kb with oligos 5screen5pnoc: CAGATTCTGTATCTATAATTTGATGGATTTGG and 3Cre5screen: ATGTTTAGCTGGCCCAAATGTTGCTGGATAGT For correct 3′ integration, we screened to obtain a 4.99 kb band with oligos 5screen5neo: GGGCCAGCTCATTCCTCCCACTCATGATCTATAGA and 3screen3pnoc: GCTCAGTTCTCTGCTCCTTTGGTTTACTGGTG ES cell clones positive for both PCRs were used in Southern blot analysis of EcoRV digested clonal DNA to obtain a single 11 kb band when single integrated. Correct targeted clones were injected into donor blastocysts to generate chimeric mice that were further bred for germline transmission. Animals heterozygous for PNOC-Cre were crossed with mice expressing Flp-recombinase in the germline to remove neo cassette flanked by FRT sites.

### Generation of POMC-IRES-eGFP mice {#sec4.4.2}

POMC-IRES-eGFP mice were created using standard protocols for generating knockin IRES-Cre mice. Specifically, to target IRES-eGFP to the Pomc gene, recombineering techniques were used ([@bib15]). A PCR amplicon containing an optimized internal ribosome entry sequence (IRES) fused to an enhanced green fluorescent protein (eGFP) sequence, followed by a FRT-flanked neomycin selection cassette, was first inserted 3 bp after the Pomc stop codon within a Pomc BAC genomic clone (bMQ314d20) obtained from the Source BioScience. The targeting construct containing the eGFP and FRT-flanked neomycin selection cassette, along with 4kb of upstream and downstream Pomc genomic DNA sequence (i.e., the homology arms), was then lifted out from the BAC clone using reverse recombineering. The resulting targeting construct was then transfected into mouse ESCs (C57BL/6N-PRX-B6N \#1, The Jackson Laboratory). Drug-selection was used to enrich for targeted clones, which were then identified by long range PCR, and injected into C57BL/6 blastocysts. Chimeric animals from blastocyst implantation were bred for germline-line transmission of the targeted Pomc gene. Animals heterozygous for the targeting event were crossed with mice expressing Flp-recombinase in the germline ([@bib23]) to remove neo cassette flanked by FRT sites ([@bib56], [@bib65]).

### Ribosome Immunoprecipitations (Phosphoribotrap) {#sec4.4.3}

Ribosome immunoprecipitations were performed according to [@bib41] with minor modifications. Protein A Dynabeads (150 μL per IP, Invitrogen) were loaded with 5 μg of pS6 antibody (Phospho-S6 (Ser244, Ser247) Polyclonal Antibody, Invitrogen, 44-923G, RRID:[AB_2533798](nif-antibody:AB_2533798){#intref0125}) in Buffer A (10 mM HEPES \[pH 7.4\], 150 mM KCl, 5 mM MgCl2, 1% NP40, 0.05% IgG-free BSA) at 4°C overnight. Beads were washed three times with Buffer A immediately before use. 10-week-old male C57/BL6N mice were put either on a NCD or a high fat diet for 3 days. Afterward, mice were sacrificed by cervical dislocation. The hypothalamus was rapidly dissected using a stainless steel brain matrix (World Precision Instruments) and immediately frozen in liquid nitrogen. Hypothalamic tissues were pooled (8 per IP, 4 IPs per condition) in a homogenization cylinder (Sartorius) and resuspended in 1.35 mL of buffer C (10 mM HEPES \[pH 7.4\], 150 mM KCl, 5 mM MgCl2, 2 mM DTT, 100 U/ml RNasin, 100 μg/ml cycloheximide, protease and phosphatase inhibitor cocktails \[1 tablet of cOmplete mini EDTA-free protease inhibitor cocktail/7ml and 2 tablets of PhosSTOP/10ml\]). Samples were homogenized 2 times at 250 rpm, and 9 times at 750 rpm on a rotating glass/teflon potter homogenizer (Potter S, Braun) at 4°C. Homogenates were transferred to low binding microcentrifuge tubes (Nonstick, RNase-free microfuge tubes, 1.5 ml, Ambion, Invitrogen) and centrifuged at 2,000xg for 10 min at 4°C. The supernatant was transferred to a new tube on ice, and to this solution was added 90 μl of 10% NP40 and 90 μl of DHPC (Avanti Polar Lipids: 100 mg/0.69 ml). This solution was mixed, incubated on ice for 2 min and then centrifuged at 17,000xg for 10 min at 4°C. The resulting supernatant was transferred to a new tube. A 25 μl aliquot was removed, transferred to a separate tube, flash frozen in liquid nitrogen and stored at 80°C for purification as input RNA. The remainder was used for immunoprecipitation (IP). Immunoprecipitations were allowed to proceed 10 minutes at 4°C during constant rotation. The beads were then washed four times with buffer D (10 mM HEPES \[pH 7.4\], 350 mM KCl, 5 mM MgCl2, 2 mM DTT, 1% NP40, 100 U/ml RNasin, and 100 μg/ml cycloheximide). After the final wash the RNA was eluted by addition of buffer RLT (350 μL) to the beads at RT, allowed to incubate at RT for 5 minutes, the beads removed by magnet, and the RNA purified using the RNeasy Micro Kit (QIAGEN). RNA integrity was assessed using an Agilent 2100 bioanalyzer. The extracted RNA of one replicate from the NCD-fed group was used for quality control and testing for enrichment of activity marker genes.

### BacTRAP-based ribosomal profiling of hypothalamic PNOC neurons {#sec4.4.4}

Affinity purification of translating ribosomes was performed as described by [@bib33], [@bib32]) with minor modifications. 10-12 week old male and female PNOC-L10a-eGFP mice were put either on a NCD or a high fat diet for 3 days. Afterward, mice were sacrificed by cervical dislocation. The hypothalamus was rapidly dissected using a stainless steel brain matrix (World Precision Instruments) and immediately frozen in liquid nitrogen. Protein A Dynabeads (375 μl, Invitrogen per IP) were washed three times in 0.15M KCl IP wash buffer (20 mM HEPES \[pH 7.4\], 5 mM MgCl~2~, 150 mM KCl, 1% NP40, 0.5 mM DTT and 100 μg/ml cycloheximide). Beads were resuspended in 275 μl 0.15M KCl IP wash buffer and were loaded with 50 μg of 19C8 and 50 μg of 19F7 (Cat\# Htz-GFP-19F7, RRID:[AB_2716736](nif-antibody:AB_2716736){#intref0130} and Htz-GFP-19C8, RRID:[AB_2716737](nif-antibody:AB_2716737){#intref0135}, Memorial Sloan Kettering Monoclonal Antibody Facility) and incubated with slow end-over-end mixing at 4°C overnight. Pooled hypothalamic tissue (4 pooled mice per sample; 4 samples per group) was homogenized in lysis buffer (20 mM HEPES \[pH 7.4\], 5 mM MgCl~2~, 150 mM KCl, 0.5 mM DTT, 40 U/ml RNasin, 100 μg/ml cycloheximide, protease and phosphatase inhibitor cocktails \[1 tablet of cOmplete mini EDTA-free protease inhibitor cocktail/7 mL and 2 tablets of PhosSTOP/10 ml\]) 2 times at 250 rpm, and 9 times at 750 rpm on a rotating glass/teflon potter homogenizer (Potter S, Braun) at 4°C. Homogenates were transferred to low binding microcentrifuge tubes (Nonstick, RNase-free microfuge tubes, 1.5 ml, Ambion, Invitrogen) and centrifuged at 2,000xg for 10 min at 4°C. The supernatant was transferred to a new tube on ice, and 1/9 sample volume 10% NP-40 (final concentration: 1%) and 1/9 sample volume 300 mM DHPC (final concentration: 30 mM) was added. This solution was mixed, incubated on ice for 2 min and then centrifuged at 17,000xg for 10 min at 4°C. The resulting supernatant was transferred to a new tube, and a 25 μl aliquot was removed, transferred to a new tube, flash frozen in liquid nitrogen and stored at 80°C for purification as input RNA. 200 μl of antibody-bound beads were added (800-1000 μl supernatant) and incubated at 4°C for one hour with end-over-end mixing. Beads were collected with a magnet and resuspended in 1000 μl of 0.35 M KCl IP wash buffer (20 mM HEPES \[pH 7.4\], 5 mM MgCl~2~, 350 mM KCl, 1% NP40, 0.5 mM DTT, 100 μg/ml cycloheximide). Beads were washed three more times with 1000 μl of 0.35 M KCl IP wash buffer. After the final wash the beads were collected with a magnet and the supernatant removed. The RNA was eluted by addition of buffer RLT (350 μL) to the beads, allowed to incubate at RT for 5 minutes and RNA was purified subsequently using the RNeasy Micro Kit (QIAGEN). RNA integrity was assessed using an Agilent 2100 bioanalyzer.

### Sequencing {#sec4.4.5}

Due to low amount of input material, pre-amplification using the Ovation RNASeq System V2 was performed. Total RNA was used for first strand cDNA synthesis, using both poly(T) and random primers, followed by second strand synthesis and isothermal strand-displacement amplification. For library preparation, the Illumina Nextera XT DNA sample preparation protocol was used, with 1 ng cDNA input. After validation (Agilent 2200 TapeStation) and quantification (Invitrogen Qubit System) all transcriptome libraries were pooled. The pool was quantified using the Peqlab KAPA Library Quantification Kit and the Applied Biosystems 7900HT Sequence Detection and sequenced on an Illumina HiSeq 4000 sequencing instrument with a 2x75bp paired-end read length. The RNA sequencing pipeline utilizes the GRCm38 assembly of the mouse genome as gene sets from Ensembl release 92 ([@bib73]). We quantified the gene expression of each sample by (1) aligning the RNA-sequencing reads to the mm10 reference genome using hisat 2.1.0 ([@bib40]), (2) computationally depleted rRNA reads using samtools 1.8.0 ([@bib42]), and (3) transcript assembly and quantification using the cufflinks 2.2.1 suite ([@bib66]). To normalize the ribosomal pulldown (IP) to the hypothalamic background (Input) per sample, we calculated a ratio of the gene abundance level (reported in *Fragments Per Kilobase Million*, FPKM) using the formula $FPKM_{ratio} = \frac{FPKM_{IP}}{FPKM_{Input}}$. For overlap analysis single-cell RNA-sequencing data of 20,921 cells from the hypothalamic arcuate-median eminence complex ([@bib10]) was used. Cells were clustered using the R Seurat package ([@bib9]). The resulting 20 cell type specific clusters were analyzed for the expression of the top 100 most enriched transcripts from the phosphoribotrap screen. An overlap with *Pnoc* mRNA was found in the neuronal clusters a17.Neurons5 and a18.Neurons6. Gene annotations and pathway analysis were performed using Ingenuity Pathway Analysis (QIAGEN).

### Immunohistochemistry {#sec4.4.6}

For immunohistochemistry assays, mice were deeply anesthetized and perfused transcardially with phosphate-buffered saline (PBS) followed by 4% paraformaldehyde (PFA). Brains were postfixed for 8 hours at 4°C and transferred to 25% sucrose in PBS for 2-3 days. 20-μm thick sections were processed for immunofluorescence as described below. Brain sections were washed (2 × 10 min) with PBS 0.1 M (pH 7.4) and incubated in blocking solution (PBS containing 0.3% Triton X-100, 3% goat serum) for 60 minutes at room temperature. Sections were incubated with the primary antibody (p-S6, rabbit, 44-923, 1:250, Thermo Fisher/Invitrogen) overnight at 4°C, washed 3 times with PBS + 0.1% Triton X-100 for 10 minutes each and incubated with the secondary antibody (Alexa 594, A11012, 1:500, Thermo Fisher/Invitrogen) for 60 minutes at room temperature, protected from light. The slides were washed 3 times with PBS + 0.1% Triton X-100 and mounted using Vectashield Antifade Mounting Medium with DAPI (Vector Laboratories). To ensure comparable immunostaining, sections were processed together under identical conditions.

### Fluorescence *in situ* hybridization {#sec4.4.7}

Deeply anaesthetized mice were perfused transcardially with phosphate-buffered saline (pH 7.4) followed by 4% paraformaldehyde (PFA) dissolved in phosphate-buffered saline (pH 7.4). The brain was removed from the skull and post-fixed in 4% PFA at room temperature (RT) overnight, and then moved to 25% sucrose solution (in 1X PBS) at 4°C for 2-3 days. 14 μm thick sections were processed as described below. Detection of *Pnoc*, Fos, *Agrp*, *Pomc*, *Slc32a1*, *Th* and *Lepr* mRNA was performed using a fluorescent *in situ* hybridization technique (RNAscope, Advanced Cell Diagnostics) according to the manufacturer's instructions. The Pnoc probe (Cat no. 437881) contained 20 oligo pairs and targeted region 325 - 1263 (Acc. No. [NM_010932.2](ncbi-n:NM_010932.2){#intref0140}) of the Pnoc transcript. 3-plex negative and 3-plex positive control probes were processed in parallel with the target probes. All incubation steps were performed at 40°C using the ACD HybEz hybridization system (Cat No. 321462). Sections were mounted on SuperFrost Plus Gold slides (ThermoFisher), dried at RT, briefly rinsed in autoclaved Millipore water, air-dried and baked at 60°C overnight. A section from the same region of the brain was also mounted for use with the negative control probe to enable calculation of background signal. Afterward, slides were submerged in Target Retrieval (Cat No. 322000) at 98.5-99.5°C for 8 min, followed by two brief rinses in autoclaved Millipore water. The slides were dehydrated in 100% ethanol and allowed to air dry for 5 min. A hydrophobic barrier was then created around the sections using an ImmEdge hydrophobic barrier pen (Cat No. 310018). Sections were incubated with Protease III (Cat No. 322340) for 35 min. The subsequent hybridization, amplification and detection steps were performed according to the manufacturer's instructions (Multiplex Fluorescent Detection kit v2, Cat No. 323110). Sections were coverslipped and counterstained with DAPI with Vectashield Antifade Mounting Medium (Vector Laboratories) and stored at 4°C in the dark.

### Imaging and quantification {#sec4.4.8}

Images were captured using a confocal Leica TCS microscope, equipped with 10x/0.30 dry and 20x/0.75 immersion objectives. Laser intensities for the probe channels were kept constant throughout the imaging process. Images of the ARC were captured from rostral to caudal, rendering approximately 5 sections per animal. Images were imported into Fiji (NIH), where the DAPI channel was enhanced regarding brightness and contrast, but the probe channels were left unmodified. The images were then imported into the Halo software (Indica Labs) for quantification of labeled neurons. The software uses the DAPI fluorescence signal for cellular identification and calculates the cell intensity for each cell and probe. The threshold for probe recognition was calculated as the mean cell intensity present in the negative control sections + 3 x standard deviation (SD).

### Electrophysiology {#sec4.4.9}

Experiments were performed on brain slices from 8-12 week-old male and female PNOC-eGFP mice that expressed enhanced green fluorescent protein (eGFP) selectively in prepronociceptin (PNOC) neurons. Animals were either fed normal chow diet or a high fat diet for three consecutive days and nights. The animals were decapitated and coronal slices (270 -- 300 μm) containing the ARC, LHA or BNST were cut with a vibration microtome (HM-650 V; Thermo Scientific, Walldorf, Germany) under cold (4°C), carbogenated (95% O~2~ and 5% CO~2~), glycerol-based modified artificial cerebrospinal fluid (GaCSF). GaCSF contained (in mM): 244 Glycerol, 2.5 KCl, 2 MgCl~2~, 2 CaCl~2~, 1.2 NaH~2~PO~4~, 10 HEPES, 21 NaHCO~3~, and 5 Glucose adjusted to pH 7.2 with NaOH. If not mentioned otherwise, the brain slices were continuously superfused with carbogenated aCSF at a flow rate of \~2.5 ml/min. aCSF contained (in mM): 125 NaCl, 2.5 KCl, 2 MgCl~2~, 2 CaCl~2~, 1.2 NaH~2~PO~4~, 21 NaHCO~3~, 10 HEPES, and 5 Glucose adjusted to pH 7.2 with NaOH. To reduce synaptic input, it contained 10^−4^ M PTX (picrotoxin, P1675, Sigma Aldrich), 5 × 10^−5^ M DL-AP5 (DL-2-amino-5-phosphonopentanoic acid, BN0086, Biotrend), and 10^−5^ M CNQX (6-cyano-7-nitroquinoxaline-2,3-dione, C127, Sigma-Aldrich).

Current-clamp recordings of PNOC-eGFP mice were performed at \~32°C in the perforated patch clamp configuration. Neurons were visualized with a fixed stage upright microscope (BX51WI, Olympus, Hamburg, Germany) using 40x and 60x water-immersion objectives (LUMplan FL/N 40x, 0.8 numerical aperture, 2 mm working distance; LUMplan FL/N 60x, 1.0 numerical aperture, 2 mm working distance, Olympus) with infrared differential interference contrast optics and fluorescence optics. PNOC-eGFP neurons were identified by their anatomical location in the ARH and by their eGFP fluorescence that was visualized with an X-Cite 120 illumination system (EXFO Photonic Solutions, Ontario, Canada) in combination with a Chroma 41001 filter set (EX: HQ480/40x, BS: Q505LP, EM: HQ535/50 m, Chroma, Rockingham, VT, USA). Electrodes with tip resistances between 4 and 6 MΩ were fashioned from borosilicate glass (0.86 mm inner diameter; 1.5 mm outer diameter; GB150-8P; Science Products) with a vertical pipette puller (PP-830; Narishige, London, UK). All recordings were performed with an EPC10 patch-clamp amplifier (HEKA, Lambrecht, Germany) controlled by the program PatchMaster (version 2.32; HEKA). In parallel, data were recorded using a micro1410 data acquisition interface and Spike 2 (version 7) (both from CED, Cambridge, UK). Data were sampled at 25 kHz and low-pass filtered at 2 kHz with a four-pole Bessel filter. The calculated liquid junction potential of 14.6 mV between intracellular and extracellular solution was compensated or subtracted offline (calculated with Patcher's Power Tools plug-in from <https://www.mpibpc.mpg.de/groups/neher/index.php?page=software> for IGOR Pro 6 (Wavemetrics, Lake Oswego, OR, USA)).

Recordings were performed with pipette solution containing (in mM): 140 K-gluconate, 10 KCl, 10 HEPES, 0.1 EGTA, 2 MgCl~2~ adjusted to pH 7.2 with KOH. ATP and GTP were omitted from the intracellular solution to prevent uncontrolled permeabilization of the cell membrane. The patch pipette was tip filled with internal solution and back filled with internal solution, which contained the ionophore to achieve perforated patch recordings and 0.02% tetramethylrhodamine-dextran (3000 MW, D3308, Invitrogen, Eugene, OR, USA) to monitor the stability of the perforated membrane. Amphotericin B (A4888; Sigma) was dissolved in dimethyl sulfoxide to a concentration of 40 μg/μl (DMSO; D8418, Sigma). The used DMSO concentration (0.1%--0.3%) had no obvious effect on the investigated neurons. The ionophore was added to the modified pipette solution shortly before use. The final concentration of amphotericin B was \~120--180 μg/mL. Amphotericin solutions were prepared from undissolved weighted samples (stored at 4°C protected from light) on every recording day. During the perforation process access resistance (R~a~) was constantly monitored and experiments were started after R~a~ had reached steady state (\~15--20 min) or the action potential amplitude was stable.

After the electrophysiological experiments, perforated-patch recordings were converted to the whole-cell configuration and biocytin was allowed to diffuse into the cell for at least 30 s. Biocytin-streptavidin labeling (1:500 streptavidin-Alexa Fluor 633, S21375, Invitrogen) combined with GFP immunohistochemistry (1:1000 chicken polyclonal anti-GFP, ab13970, abcam; 1:500 goat anti-chicken Alexa Fluor 488, ab150173, abcam) was performed as previously described ([@bib31]). For the overviews shown in [Figure 1](#fig1){ref-type="fig"}D slices were stained for GFP only. Fluorescence images were captured with a confocal microscope (SP8, Leica) equipped with PL APO 10x/0.40, PL APO 20x/0.75 IMM and PL APO 63/1.2 objectives. Scaling, z-projections and adjustments of brightness and contrast were done using ImageJ/Fiji.

### Glucose and leptin sensitivity {#sec4.4.10}

Glucose sensitivity was analyzed with perforated patch clamp recordings and protocols modified from [@bib14]. Glucose sensitivity was assessed lowering the extracellular glucose concentration stepwise from 5 mM to 0.1 mM. D-Mannitol (A4831, AppliChem, Germany) was used to adjust osmolarity. The effect of changes in glucose concentration or leptin (100 nM; L3772, Sigma-Aldrich, Taufkirchen, Germany) was measured after 25-30 min when the spike frequency or membrane potential had stabilized. To test the significance of the responses of individual neurons, means and standard deviations of action potential frequency and membrane potential were calculated from 12 bins each 10 s long. Significance was accepted at p ≤ 0.001 in paired t tests.

### ChR2-assisted circuit mapping (CRACM) {#sec4.4.11}

PNOC-Cre::POMC-IRES-eGFP mice were unilaterally injected with pAAV-EF1a-double floxed-hChR2(H134R)-mCherry-WPRE-HGHpA (AAV1) in the ARC and allowed 3 weeks for virus expression. Mice were decapitated and brains were quickly removed into ice-cold cutting solution consisting of (in mM): 92 choline chloride, 30 NaHCO3, 25 Glucose, 20 HEPES, 10 MgSO4, 2.5 KCl, 1.25 NaH2PO4, 5 sodium ascorbate, 3 sodium pyruvate, 2 thiourea, 0.5 CaCl2; oxygenated with 95% O2/5% CO2; measured osmolarity 310--320 mOsm/L. 300 μm thick coronal sections were cut with a Campden vibratome (Model 7000smz-2) and incubated in oxygenated cutting solution at 34 °C for 10 min. Slices were transferred to oxygenated aCSF (consisting of (in mM): 126 NaCl, 21.4  NaHCO3, 2.5 KCl, 1.2  NaH2PO4, 1.2 MgCl2, 2.4 CaCl2, 10 glucose) at 34 °C for 30 min, and stored in the same solution at room temperature (20--24 °C) for at least 60 min prior to recording. A single slice was placed in the recording chamber where it was continuously superfused at a rate of 3--4 mL per min with oxygenated aCSF. Neurons were visualized with an upright microscope (SliceScope, Scientifica) equipped with infrared-differential interference contrast and fluorescence optics. Borosilicate glass microelectrodes (3-5 MΩ) were filled with a Cs+-based internal solution consisting of (in mM): 135 CsMeSO3, 10 HEPES, 1 EGTA, 4 MgCl2, 4 Na2-ATP, 0.4 Na2-GTP, 10 Na2-phosphocreatine (pH 7.3 adjusted with CsOH; 295 mOsm/L). To photostimulate ChR2-expressing PNOC^ARC^ cell bodies and terminals, an LED light source (473 nm) was focused onto the back aperture of the microscope objective, producing widefield exposure around recorded cells. Light-evoked IPSCs were recorded from GFP-positive POMC neurons in whole-cell voltage-clamp mode, with membrane potential clamped at V~h~ = 0 mV. At the end of the recordings, bicuculline (10 μM) was added to the aCSF to block GABAergic synaptic transmission. All recordings were made using a Multiclamp 700B amplifier, and data were filtered at 2 kHz and digitized at 10 kHz. The light-evoked IPSC detection protocol consisted of four blue light pulses (473 nm wavelength, 5 ms) administered 1 s apart during the first 4 s of an 8 s sweep. Evoked IPSCs with short latency (\< 10 ms) upon light stimulation and low jitter were considered light-driven. Light output was controlled by a programmable pulse stimulator, Master-8 (A.M.P.I.) and pClamp software (Axon Instruments). All recordings were analyzed offline using Clampfit.

### sIPSCs in POMC neurons {#sec4.4.12}

POMC-IRES-eGFP mice were either fed NCD or HFD for 3 days prior to the experiment. Brain slices were prepared as outlined above (ChR2-assisted circuit mapping) and sIPSCs recordings from POMC neurons were obtained in voltage-clamp mode at V~h~ = −70 mV. Borosilicate glass microelectrodes (3-5 MΩ) were filled with a CsCl-based internal solution consisting of (in mM): 140 CsCl, 2 NaCl, 10 HEPES, 5 EGTA, 2 MgCl2, 0.5 CaCl2, 2 Na-ATP, 0.5 Na-GTP, 2 QX-314, pH of 7.3 with CsOH). sIPSCs were recorded in presence of CNQX (10 μM) to block glutamatergic synaptic transmission. Recordings with an R~a~ change of \> 20% were discarded from analysis. sIPSC frequency and mean peak amplitude were determined using WinEDR (version 3.8.6). The entire duration of each analyzed recording was manually inspected (1-2 minute duration).

### Stereotaxic surgical procedures {#sec4.4.13}

For all stereotaxic surgeries, animals were anesthetized with isoflurane and placed into a stereotaxic apparatus. For pain relief and postoperative care, mice were injected with buprenorphine (0.1 mg/kg) and meloxicam (5 mg/kg). Post-surgery, animals received tramadol in the drinking water (1 mg/mL), were inspected twice daily and body weight was monitored to ensure regain of pre-surgery weight.

#### Fiber implantation {#sec4.4.13.1}

Optical fibers (fiber core = 200 μm, NA = 0.48, flat tip; Doric Lenses Inc.) were implanted unilaterally over the ARC (coordinates from bregma AP: −1.45 mm, DV: −5.5, ML: 0) and fixed to the skull using dental acrylic.

For projection stimulation experiments PNOC-Cre and control mice were unilaterally injected (coordinates from bregma AP: −1.45 mm; ; ML: −0.20 mm; DV: −5.87 mm) with 25 nL pAAV-EF1a-double floxed-hChR2(H134R)-EYFP-WPRE-HGHpA (AAV1). For stimulation of BNST projections optical fibers were implanted unilaterally over the BNST (coordinates from bregma AP: 0.45; ML: −0.50; DV: −3.8). For stimulation of LHA/PMD projections optical fibers were implanted over the LHA/PMD (coordinates from bregma AP:-2.5; ML: −0.5; DV: −4.6).

#### Viral injections {#sec4.4.13.2}

For PNOC^ARC^ projection mapping 25 nL of pAAV-EF1a-double floxed-hChR2(H134R)-EYFP-WPRE-HGHpA (AAV1) was unilaterally injected into the ARC (coordinates from bregma AP: −1.45 mm; ML: ± 0.20 mm; DV: −5.95 mm). Mice with missed injections or expression outside the ARC were excluded from analysis after post hoc examination of EYFP expression.

For CRACM experiments, 10-15 nL of pAAV-EF1a-double floxed-hChR2(H134R)-mCherry-WPRE-HGHpA (AAV1) was unilaterally injected into the ARC (coordinates from bregma AP: −1.45 mm; ML: ± 0.20 mm; DV: −5.95 mm) of PNOC-Cre::POMC-IRES-eGFP mice.

75 nL of AAV expressing AAV-flex-taCasp3-TEVp (2.8 x10^12^ particles/ml) was bilaterally injected into the ARC (coordinates from bregma AP: −1.45 mm; ML: ± 0.20 mm; DV: −5.95 mm) and the pipette was withdrawn 5 min after injection.

### *In vivo* optogenetic studies {#sec4.4.14}

A fiber optic cable was firmly attached to the implanted fiber optic cannula. ChR2-Pnoc and control ChR2-wild-type mice were acclimated to this procedure in their experimental cages for one week prior to optogenetic stimulation. Blue laser light stimulation (473 nm, output power of 15 mW at the tip of the patch cord) consisting of pulse trains (5 ms pulses of 20 Hz; 1 s on, 3 s off) was delivered. For photostimulation of PNOC^ARC^ projections to the LHA/PMD and BNST blue laser light stimulation (473 nm, output power of 10 mW at the tip of the patch cord) consisting of pulse trains (5 ms pulses of 20 Hz; 1 s on, 3 s off) was delivered. The location of the fiber tip was identified using histology of the brain tissue. Mice with fiber placement outside of the target region were excluded from analysis.

### Indirect Calorimetry {#sec4.4.15}

Indirect calorimetry was performed using an indirect calorimetry system from TSE systems (PhenoMaster, TSE systems). Mice were placed in training cages for three days prior to data acquisition to adapt to the pellet and liquid dispensers of the system. For the measurement mice were placed in regular type II cages with sealed lids at room temperature (22°C) and allowed to adapt to the chambers for at least 24 hours. Food and water were provided *ad libitum*. All parameters were measured continuously and simultaneously.

Indirect calorimetry during optogenetic stimulation was performed using an indirect calorimetry system from Sable Systems (Promethion, Sable Systems, Las Vegas, NV). Mice were placed in the calorimetric cages for three days prior to data acquisition to adapt to the pellet and liquid dispensers of the system. Food and water were provided *ad libitum*. Obtained raw data was processed using ExpeData v. 1.9.22 (Sable Systems, Las Vegas, NV) using an analysis script for data transformation.

### Real time place preference/aversion test {#sec4.4.16}

Real time place preference/aversion test was performed in a custom-built wooden enclosure (30x50x20 cm), consisting of two interconnected chambers. The experiment was conducted in two sessions, 30 min each (baseline recording on the day 1 and a stimulation session two days later). During the baseline session, mice were connected to the patchords and placed in the enclosure, but no laser light was delivered. During the stimulation session, optogenetic stimulation consisted of 1 s of blue light pulses (473 nm, 5 ms pulse width, 20 Hz) followed by 1 s of delay. For optogenetic stimulation, the patch cord was connected to a 473-nm diode-pumped solid-state laser (R471005FX, Laserglow Technologies) with an FC/PC adaptor. The stimulation was delivered by the AnyMaze behavior tracking software (Stoelting, USA) when animal entered one of the compartments (stimulation compartment) until the mouse crossed back into the non-stimulation side. The stimulation compartment was assigned in a counterbalanced manner. Behavioral data was recorded using the Digital USB 2.0 CMOS Camera (The Imaging Source Europe GmbH, Germany), scored and analyzed in AnyMaze.

### Conditioned place preference/aversion test {#sec4.4.17}

Conditioned place preference/aversion test was conducted using a 4 days protocol as described previously ([@bib63], [@bib75]) in a three-chambered setup. It was performed in a custom-built wooden enclosure, consisting of two chambers (30x20x20 cm each) with distinct wall features, and separated by a corridor (30x10x20 cm). The experiment consisted of 4 sessions (15 min baseline recording on the Day 1; conditioning sessions, 30 min each, on Day 2 and 3; 15 min test on Day 4). During the conditioning sessions, optogenetic stimulation consisted of 1 s of blue (473 nm) light pulses (5 ms pulse width, 20 Hz) followed by 1 s of delay and was activated when the animal entered the conditioned chamber. The conditioned chamber was assigned in a counterbalanced manner. For optogenetic stimulation, the patch cord was connected to a 473-nm diode-pumped solid-state laser (R471005FX, Laserglow Technologies) with an FC/PC adaptor. The stimulation was delivered by the Any-Maze behavioral tracking software (Stoelting Co, the USA). Behavioral data was recorded using the Digital USB 2.0 CMOS Camera (The Imaging Source Europe GmbH, Germany), scored and analyzed in Any-Maze and GraphPad Prism.

### PET Imaging {#sec4.4.18}

PET imaging was performed as described in [@bib38] using an Inveon preclinical PET/CT system (Siemens). Mice were anesthetized with 2% isoflurane in 65%/35% nitrous oxide/oxygen gas and positioned on a dedicated mouse carrier (MEDRES, Germany) carrying two mice. A fiber optic cable was firmly attached to the implanted fiber optic cannula. For injection of the radiotracer, a catheter consisting of a 30G cannula connected to a polythene tubing (ID = 0.28 mm) was inserted into the tail vein and fixated by a drop of glue. After starting the PET scan, 7-8 MBq of \[18F\]FDG in 50-100 μL saline were injected per mouse and blue laser (473 nm) light stimulation (output power of 15 mW) consisting of pulse trains (5 ms pulses of 20 Hz; 1 s on, 3 s off) was delivered. Emission data were acquired for 45 minutes. Thereafter, animals were automatically moved into the CT gantry and a CT scan was performed (180 projections/360°, 200 ms, 80 kV, 500 μA). The CT data were used for attenuation correction of the PET data and the CT image of the scull was used for image co-registration. Plasma glucose levels were determined from a tail vein blood sample using a standard glucometer (Bayer) after removing the tail vein catheters. PET data were histogrammed in time frames of 12x30s, 3x60s, 3x120s, 7x240s, Fourier rebinned, and images were reconstructed using the MAP-SP algorithm provided by the manufacturer. For co-registration the imaging analysis software Vinci was used ([@bib13]). Images were co-registered to a 3D mouse brain atlas constructed from the 2D mouse brain atlas published by Paxinos ([@bib51]). An image-derived input function was extracted from the PET data of the aorta, which could be identified in the image of the first time frame of each animal. Input function data were corrected for partial volume effect by assuming a standardized volume fraction of 0.6 ([@bib28]). Parametric images of the \[18F\]FDG kinetic constants K1, k2, k3, and k4 were determined by a voxel-by-voxel (voxel size = 0.4 mm x 0.4 mm x 0.8 mm) fitting of data to a two- tissue-compartment kinetic model. The ratio of tissue and plasma glucose concentrations (C~E~/C~P~) is a measure for glucose transport and is given by C~E~/C~P~ = K1/(k2+k3/0.26) ([@bib2], [@bib38]). Since neuronal activation is accompanied by increased glucose transport and this parameter is less sensitive to changes in plasma glucose level, we use alterations of glucose transport (C~E~/C~P~) as surrogate for alterations in neuronal activation. Statistical testing was performed by application of a voxel-wise t test between groups. 3D maps of p values allow for identification of regions with significant differences in the parameters. From these regions we defined volumes of interest (VOIs) and performed additional statistical testing for these VOIs. For presentation only, 3D maps of p values were re-calculated on a 0.1 mm x 0.1 mm x 0.1 mm grid from the original dataset using trilinear interpolation.

### Analysis of Body Composition {#sec4.4.20}

Body composition was analyzed using micro-computed tomography (micro-CT)-based imaging of isoflurane-anesthetized mice. Data acquisition was performed in an IVIS Spectrum CT-scanner (Calpier LifeScience, USA) using the IVIS LivingImage Software V4.3.1. Quantification of fat mass was performed with a modification of the Vinci software package 4.61.0 ([@bib13]).

### Insulin tolerance test {#sec4.4.21}

Insulin tolerance tests (ITTs) were performed in random fed mice. Food was removed and bedding was renewed prior to starting the experiment. Blue laser (473 nm) light stimulation (output power of 15 mW) consisting of pulse trains (5 ms pulses of 20 Hz; 1 s on, 3 s off) was delivered starting 3 hours prior to the experiment and continued throughout the experiment. Blood glucose concentrations were measured from whole venous blood using an automatic glucose monitor (Contour Ascensia, Bayer HealthCare, Germany). Following determination of body weights and basal blood glucose concentrations, mice received an intraperitoneal injection of 0.75 U/kg body weight of human insulin (Insuman® Rapid, Sanofi Aventis) dissolved in saline and blood glucose concentrations were measured again at 15, 30, and 60 min post injection. Food was withdrawn over the whole course of the experiment.

### Glucose tolerance test {#sec4.4.22}

Glucose tolerance tests (GTTs) were performed in mice that had been fasted for 16 hours overnight. Blue laser (473 nm) light stimulation (output power of 15 mW) consisting of pulse trains (5 ms pulses of 20 Hz; 1 s on, 3 s off) was delivered starting 3 hours prior to the experiment and continued throughout the experiment. Following determination of body weights and basal blood glucose concentrations, mice received an intraperitoneal injection of 20% glucose (10 mL/kg body weight; beta-pharm) and blood glucose levels were measured again at 15, 30, 60, and 120 min post injection. Blood samples for glucose measurement were collected from the tail vein. Glycemia was assessed using a Contour glucometer (Bayer).

Quantification and Statistical Analysis {#sec4.5}
---------------------------------------

The number of replicates (n) are indicated in the figure legends. For electrophysiology experiments, n represents the number of recorded neurons. For RNA sequencing experiments, n represents the number of technical replicates (details on the number of mice pooled for each replicate can be found in the '[Ribosome Immunoprecipitations (Phosphoribotrap)](#sec4.4.3){ref-type="sec"}' or in the '[BacTRAP-Based Ribosomal Profiling of Hypothalamic PNOC Neurons](#sec4.4.4){ref-type="sec"}' section of [STAR Methods](#sec4){ref-type="sec"}. For all other experiments, n represents the number of mice (unless otherwise stated). Data are presented as Box-whisker plots or as violin plots with upper and lower quartile, median, the minimum and maximum values. For all statistical tests, significance was measured against an alpha value of 0.05 unless otherwise stated. ^∗^ p \< 0.05, ^∗∗^ p \< 0.01, ^∗∗∗^ p \< 0.001. All error bars show s.e.m. No statistical methods were used to predetermine sample sizes, but group sizes commonly applied in murine studies were used. All statistical analyses were performed using GraphPad Prism software unless noted otherwise. Electrophysiology analysis was performed with Spike2 (version 7; Cambridge Electronic Design Ltd., Cambridge, UK), Igor Pro 6 (Wavemetrics, Portland, OR, USA) and Graphpad Prism (version 5.0b; Graphpad Software Inc., La Jolla, CA, USA). If not stated otherwise, all calculated values are expressed as means ± SEM (standard error of the mean). For pairwise comparisons of dependent and independent normal distributions paired and unpaired t tests were used, respectively. For pairwise comparisons of independent, not normal distributions Mann-Whitney U-test was used. Tests were executed using GraphPad Prism 5 (GraphPad Software Inc., La Jolla, CA, USA). Neurons with action potential frequencies below 0.5 Hz were defined as silent.
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